[Form 4] Vicarious Surgical Inc. Insider Trading Activity
Adam David Sachs, a director, 10% owner and President of Vicarious Surgical Inc. (RBOT), reported a non-discretionary sale on 09/03/2025 of 463 shares of Class A common stock to satisfy tax-withholding obligations from restricted stock units granted on June 2, 2023. The transactions were executed as a "sell-to-cover" under the companys equity plan at a weighted average price of $5.7564 per share (trades ranged from $5.64 to $5.87). After the sale, the reporting person beneficially owned 49,164 shares directly. The Form 4 was submitted by an attorney-in-fact on 09/04/2025.
Adam David Sachs, direttore, proprietario del 10% e Presidente di Vicarious Surgical Inc. (RBOT), ha registrato una vendita non discrezionale in data 03/09/2025 di 463 azioni di azioni ordinarie di Classe A per soddisfare obblighi di ritenuta fiscale su unit脿 di azioni soggette a restrizioni assegnate il 2 giugno 2023. Le operazioni sono state eseguite come "sell-to-cover" nell'ambito del piano azionario della societ脿 a un prezzo medio ponderato di $5,7564 per azione (i trade sono variati da $5,64 a $5,87). Dopo la vendita, la persona segnalante possedeva direttamente in via beneficiaria 49.164 azioni. Il Modulo 4 猫 stato presentato da un procuratore il 04/09/2025.
Adam David Sachs, director, propietario del 10% y presidente de Vicarious Surgical Inc. (RBOT), report贸 una venta no discrecional el 03/09/2025 de 463 acciones de acciones ordinarias Clase A para cubrir obligaciones fiscales por unidades de acciones restringidas concedidas el 2 de junio de 2023. Las transacciones se realizaron como "sell-to-cover" bajo el plan de acciones de la empresa a un precio medio ponderado de $5.7564 por acci贸n (las operaciones oscilaron entre $5.64 y $5.87). Tras la venta, la persona informante pose铆a beneficiosamente 49.164 acciones en propiedad directa. El Formulario 4 fue presentado por un apoderado el 04/09/2025.
Adam David Sachs電� Vicarious Surgical Inc.(RBOT)鞚� 鞚挫偓鞚挫瀽 10% 歆�攵� 氤挫湢鞛� 瓴� 靷灔鞙茧, 2025-09-03鞐� 鞝滍暅欤检嫕雼渼(RSU)鞐� 雽�頃� 靹戈笀 鞗愳矞歆曥垬 鞚橂毳� 於╈”頃橁赴 鞙勴暣 463欤�鞚� 韥措灅鞀� A 氤错喌欤茧ゼ 牍勳瀯鞚橃爜(non-discretionary)鞙茧 毵る弰頄堨姷雼堧嫟. 頃措嫻 瓯半灅電� 須岇偓 欤检嫕 氤挫儊 瓿勴殟鞐� 霐半澕 "sell-to-cover" 氚╈嫕鞙茧 觳搓舶霅橃棃鞙茧┌, 臧�欷戫弶攴� 臧�瓴╈潃 欤茧嫻 $5.7564(瓯半灅 氩旍渼 $5.64~$5.87)鞓�鞀惦媹雼�. 毵る弰 頉� 氤搓碃鞛愲姅 歆侅爲鞝侅溂搿� 順滍儩鞝� 靻岇湢毳� 韱淀暣 49,164欤�毳� 氤挫湢頃橁碃 鞛堨棃鞀惦媹雼�. 頃措嫻 Form 4電� 2025-09-04鞐� 雽�毽澑鞐� 鞚橅暣 鞝滌稖霅橃棃鞀惦媹雼�.
Adam David Sachs, administrateur, d茅tenteur de 10 % et pr茅sident de Vicarious Surgical Inc. (RBOT), a d茅clar茅 une vente non discr茅tionnaire le 03/09/2025 de 463 actions ordinaires de classe A afin de couvrir des obligations fiscales li茅es 脿 des unit茅s d'actions restreintes attribu茅es le 2 juin 2023. Les op茅rations ont 茅t茅 effectu茅es en 芦 sell-to-cover 禄 dans le cadre du plan d'int茅ressement en actions de la soci茅t茅 脿 un prix moyen pond茅r茅 de 5,7564 $ par action (transactions comprises entre 5,64 $ et 5,87 $). Apr猫s la vente, la personne d茅clarant d茅tenait directement et 脿 titre b茅n茅ficiaire 49 164 actions. Le formulaire 4 a 茅t茅 d茅pos茅 par un mandataire le 04/09/2025.
Adam David Sachs, Direktor, 10% Eigent眉mer und Pr盲sident von Vicarious Surgical Inc. (RBOT), meldete am 03.09.2025 einen nicht-diskretion盲ren Verkauf von 463 Aktien der Stammaktien Klasse A, um Steuerabzugsverpflichtungen aus am 2. Juni 2023 gew盲hrten Restricted Stock Units zu erf眉llen. Die Transaktionen wurden als "sell-to-cover" im Rahmen des Aktienplans des Unternehmens ausgef眉hrt zu einem gewichteten Durchschnittspreis von $5,7564 pro Aktie (Handelsspanne $5,64 bis $5,87). Nach dem Verkauf besa脽 die meldende Person wirtschaftlich direkt 49.164 Aktien. Das Formular 4 wurde am 04.09.2025 durch einen Bevollm盲chtigten eingereicht.
- Transaction disclosed as non-discretionary sell-to-cover to satisfy RSU tax withholding, improving transparency
- Complete price disclosure with weighted average ($5.7564) and range ($5.64$5.87), enabling clear understanding of execution
- None.
Insights
TL;DR: Small, mandatory insider sale to cover taxes; not indicative of discretionary liquidation.
The sale of 463 shares at roughly $5.76 was executed to satisfy tax withholding tied to RSU vesting and was mandated by the issuers equity plan. The size of the transaction is immaterial relative to the reporting persons remaining holding of 49,164 shares and does not signal a change in control or strategic shift. Investors should note transaction type and price range, but this Form 4 reflects routine equity-compensation mechanics rather than a voluntary insider disposition.
TL;DR: Filing shows compliance with Rule 16 reporting and companys sell-to-cover policy.
The Form 4 transparently documents a tax-withholding sale tied to RSU vesting and includes disclosure of the weighted average sale price and price range. The use of an attorney-in-fact to file the Form 4 and the explanatory footnotes align with standard governance practices. There are no indications of undisclosed related-party transactions or governance irregularities in this filing.
Adam David Sachs, direttore, proprietario del 10% e Presidente di Vicarious Surgical Inc. (RBOT), ha registrato una vendita non discrezionale in data 03/09/2025 di 463 azioni di azioni ordinarie di Classe A per soddisfare obblighi di ritenuta fiscale su unit脿 di azioni soggette a restrizioni assegnate il 2 giugno 2023. Le operazioni sono state eseguite come "sell-to-cover" nell'ambito del piano azionario della societ脿 a un prezzo medio ponderato di $5,7564 per azione (i trade sono variati da $5,64 a $5,87). Dopo la vendita, la persona segnalante possedeva direttamente in via beneficiaria 49.164 azioni. Il Modulo 4 猫 stato presentato da un procuratore il 04/09/2025.
Adam David Sachs, director, propietario del 10% y presidente de Vicarious Surgical Inc. (RBOT), report贸 una venta no discrecional el 03/09/2025 de 463 acciones de acciones ordinarias Clase A para cubrir obligaciones fiscales por unidades de acciones restringidas concedidas el 2 de junio de 2023. Las transacciones se realizaron como "sell-to-cover" bajo el plan de acciones de la empresa a un precio medio ponderado de $5.7564 por acci贸n (las operaciones oscilaron entre $5.64 y $5.87). Tras la venta, la persona informante pose铆a beneficiosamente 49.164 acciones en propiedad directa. El Formulario 4 fue presentado por un apoderado el 04/09/2025.
Adam David Sachs電� Vicarious Surgical Inc.(RBOT)鞚� 鞚挫偓鞚挫瀽 10% 歆�攵� 氤挫湢鞛� 瓴� 靷灔鞙茧, 2025-09-03鞐� 鞝滍暅欤检嫕雼渼(RSU)鞐� 雽�頃� 靹戈笀 鞗愳矞歆曥垬 鞚橂毳� 於╈”頃橁赴 鞙勴暣 463欤�鞚� 韥措灅鞀� A 氤错喌欤茧ゼ 牍勳瀯鞚橃爜(non-discretionary)鞙茧 毵る弰頄堨姷雼堧嫟. 頃措嫻 瓯半灅電� 須岇偓 欤检嫕 氤挫儊 瓿勴殟鞐� 霐半澕 "sell-to-cover" 氚╈嫕鞙茧 觳搓舶霅橃棃鞙茧┌, 臧�欷戫弶攴� 臧�瓴╈潃 欤茧嫻 $5.7564(瓯半灅 氩旍渼 $5.64~$5.87)鞓�鞀惦媹雼�. 毵る弰 頉� 氤搓碃鞛愲姅 歆侅爲鞝侅溂搿� 順滍儩鞝� 靻岇湢毳� 韱淀暣 49,164欤�毳� 氤挫湢頃橁碃 鞛堨棃鞀惦媹雼�. 頃措嫻 Form 4電� 2025-09-04鞐� 雽�毽澑鞐� 鞚橅暣 鞝滌稖霅橃棃鞀惦媹雼�.
Adam David Sachs, administrateur, d茅tenteur de 10 % et pr茅sident de Vicarious Surgical Inc. (RBOT), a d茅clar茅 une vente non discr茅tionnaire le 03/09/2025 de 463 actions ordinaires de classe A afin de couvrir des obligations fiscales li茅es 脿 des unit茅s d'actions restreintes attribu茅es le 2 juin 2023. Les op茅rations ont 茅t茅 effectu茅es en 芦 sell-to-cover 禄 dans le cadre du plan d'int茅ressement en actions de la soci茅t茅 脿 un prix moyen pond茅r茅 de 5,7564 $ par action (transactions comprises entre 5,64 $ et 5,87 $). Apr猫s la vente, la personne d茅clarant d茅tenait directement et 脿 titre b茅n茅ficiaire 49 164 actions. Le formulaire 4 a 茅t茅 d茅pos茅 par un mandataire le 04/09/2025.
Adam David Sachs, Direktor, 10% Eigent眉mer und Pr盲sident von Vicarious Surgical Inc. (RBOT), meldete am 03.09.2025 einen nicht-diskretion盲ren Verkauf von 463 Aktien der Stammaktien Klasse A, um Steuerabzugsverpflichtungen aus am 2. Juni 2023 gew盲hrten Restricted Stock Units zu erf眉llen. Die Transaktionen wurden als "sell-to-cover" im Rahmen des Aktienplans des Unternehmens ausgef眉hrt zu einem gewichteten Durchschnittspreis von $5,7564 pro Aktie (Handelsspanne $5,64 bis $5,87). Nach dem Verkauf besa脽 die meldende Person wirtschaftlich direkt 49.164 Aktien. Das Formular 4 wurde am 04.09.2025 durch einen Bevollm盲chtigten eingereicht.
FAQ
What did Adam David Sachs sell according to the Form 4 for RBOT?
Why were the RBOT shares sold in this Form 4?
What price did the RBOT shares sell for?
How many RBOT shares does the reporting person own after the sale?
Who filed the Form 4 for this RBOT transaction?
